Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose Pharmacokinetics and Safety of Daclatasvir in Subjects With Renal Function Impairment

NCT01830205 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT01830205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01830205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose Pharmacokinetics and Safety of Daclatasvir in Subjects With Renal Function Impairment
Lead sponsor
Bristol-Myers Squibb
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2012
Completion date
June 30, 2013
Enrollment
58 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c